5XCV | Immune System | date | Mar 23, 2017 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
title | Crystal Structure Of Nz-1 Fv-Clasp Fragment With Its Antigen | ||||||||||||||
authors | T.Arimori, J.Takagi | ||||||||||||||
compound | source | ||||||||||||||
Molecule: Vh(S112c)-Sarah Chimera,Vh(S112c)-Sarah Chimera Chain: A, D Engineered: Yes |
Organism_scientific: Rattus, Homo Sapiens Organism_common: Human Organism_taxid: 10114, 9606 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
Molecule: Vl-Sarah(S37c) Chimera,Vl-Sarah(S37c) Chimera Chain: B, E Engineered: Yes |
Organism_scientific: Rattus, Homo Sapiens Organism_common: Human Organism_taxid: 10114, 9606 Expression_system: Escherichia Coli Expression_system_taxid: 562 | ||||||||||||||
Molecule: Pa14 Peptide Chain: C, F Engineered: Yes |
Synthetic: Yes Organism_scientific: Homo Sapiens Organism_taxid: 9606 | ||||||||||||||
symmetry | Space Group: C 1 2 1 |
| |||||||||||||
crystal cell |
| ||||||||||||||
method | X-Ray Diffraction | resolution | 2.14 Å | ||||||||||||
ligand | CA | enzyme |
| ||||||||||||
Gene Ontology |
| ||||||||||||||
Primary reference | Fv-clasp: An Artificially Designed Small Antibody Fragment with Improved Production Compatibility, Stability, and Crystallizability., Arimori T, Kitago Y, Umitsu M, Fujii Y, Asaki R, Tamura-Kawakami K, Takagi J, Structure. 2017 Sep 6. pii: S0969-2126(17)30264-2. doi:, 10.1016/j.str.2017.08.011. PMID:28919443 |
Data retrieval |
View 5XCV in 3D |
Visual 3D analysis of 5XCV |
Structure-derived information |
Sequence-derived information |
Other resources with information on 5XCV |
OCA© by Jaime Prilusky, 1996-2014,2022 Bioinformatics Unit Weizmann Institute of Science |